ADMA Biologics, Inc. Annual report pursuant to section 13 and 15(d)

Annual report pursuant to section 13 and 15(d)

5. NOTES PAYABLE TO SIGNIFICANT STOCKHOLDERS (Tables)

5. NOTES PAYABLE TO SIGNIFICANT STOCKHOLDERS (Tables)

12 Months Ended

Dec. 31, 2012

Notes Payable To Significant Stockholders Tables

Schedule of notes payable

Issue Date		Principal December 31, 2010				Principal Issued in 2011				Principal Converted in 2011				Principal Repaid in 2011				Principal December 31, 2011				Interest Rate				Conversion Price

Aug-09		$	2,500,000			$	---			$	(2,500,000	) *		$	---			$	---				9	%		$	1.9930
Dec-09			2,500,000				---				(2,500,000	) *			---				---				9	%		$	1.9930
Jun-10			1,800,000				---				(1,800,000	) *			---				---				12	%		$	1.9930
Dec-10			500,000				---				(500,000	) *			---				---				10	%		$	1.9930
Feb-11			---				300,000				(300,000	) *			---				---				10	%		$	1.9930
May-11			---				250,000				(250,000	) *			---				---				10	%		$	1.9930
Jun-11			---				300,000				(300,000	) *			---				---				10	%		$	1.9930
Aug-11			---				250,000				---				---				250,000				10	%		$	1.9930
Sep-11			---				100,000	**			---				(100,000	)			---				18	%			---
Oct-11			---				100,000	**			---				(100,000	)			---				18	%			---
Dec-11			---				200,000				---				---				200,000				18	%			---
		$	7,300,000			$	1,500,000			$	(8,150,000	)		$	(200,000	)		$	450,000